Connect with us

Business

Novavax Covid-19 Vaccine Faces Delay – The Wall Street Journal

A shortage of raw materials will push back several regulatory and manufacturing targets for the vaccine, which is in the final stage of testing

Published

on

Article feature image
ADVERTISEMENT

Novavax Inc. has delayed plans to seek regulatory clearances for its Covid-19 vaccine, while shortages in raw materials are slowing the ramp-up in production of doses, the company said.
The delays may set back efforts to increase vaccinations in developing countries, which have been dealing with limited doses of currently available shots and are looking forward to Novavaxs.
Previously, Novavax said it expected to complete requests for regulatory authorizations of its Covid-19 vaccine in the U.S.,…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
VIDEO: American crew insulted, steward threatens to turn plane around – Business Insider
Article feature image
Inside one woman’s effort to normalize marijuana in homes and get equity ‘baked into the laws.’ – NBC News
Article feature image
Child found at Aurora Golden Corral, police looking for family – FOX 31 Denver